Financial Survey: PPJ Enterprise (OTCMKTS:PPJE) vs. Schrodinger (NASDAQ:SDGR)

PPJ Enterprise (OTCMKTS:PPJE) and Schrodinger (NASDAQ:SDGR) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings and analyst recommendations.

Risk and Volatility

PPJ Enterprise has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, Schrodinger has a beta of 1.79, indicating that its share price is 79% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations for PPJ Enterprise and Schrodinger, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PPJ Enterprise	0	0	0	0	0.00
Schrodinger	0	2	4	0	2.67

Schrodinger has a consensus target price of $27.83, indicating a potential upside of 46.72%. Given Schrodinger’s stronger consensus rating and higher possible upside, analysts clearly believe Schrodinger is more favorable than PPJ Enterprise.

Valuation & Earnings

This table compares PPJ Enterprise and Schrodinger”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PPJ Enterprise	$670,000.00	1.33	$10,000.00	N/A	N/A
Schrodinger	$207.54 million	6.73	-$187.12 million	($2.48)	-7.65

PPJ Enterprise has higher earnings, but lower revenue than Schrodinger.

Institutional & Insider Ownership

79.1% of Schrodinger shares are held by institutional investors. 21.0% of Schrodinger shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares PPJ Enterprise and Schrodinger’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PPJ Enterprise	N/A	N/A	N/A
Schrodinger	-76.22%	-45.70%	-24.81%

Summary

Schrodinger beats PPJ Enterprise on 8 of the 12 factors compared between the two stocks.

About PPJ Enterprise

PPJ Healthcare Enterprises, Inc., through its subsidiaries, provides automated healthcare reimbursement cycle, online health information digital-systems, and practice information management digital-system software to health care providers and general businesses worldwide. The company offers the Automated Biller, a medical billing system that allows physicians to bill their medical insurance claims at the point of service without data entry, coding, or billing personnel. It also provides billing, specialty medical billing, collection, and workers comp lien collection services for health care providers in the areas of pain management, anesthesia and surgery centers practices, and various specialties of medicine. The company was formerly known as PPJ Enterprise and changed its name to PPJ Healthcare Enterprises, Inc. in October 2014. PPJ Healthcare Enterprises, Inc. was founded in 2000 and is headquartered in Reno, Nevada.

About Schrodinger

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.